|
?:authorAffiliation
|
-
[\'Equipe Labellisée Par La Ligue Contre Le Cancer, Université De Paris, Sorbonne Université, INSERM U1138, Centre De Recherche Des Cordeliers, Paris, France.\', \'Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.\', \'Faculty of Medicine Kremlin Bicêtre, Université Paris Saclay, Paris, France.\', \'Hematology Department and Biosurgical Research Lab, (Carpentier Foundation) Assistance Publique Hôpitaux De Paris-Centre Université De Paris (APHP-CUP), Paris, France.\', \'Innovative Therapies in Haemostasis, INSERM, Université De Paris, Paris, France.\', \'Biological Hematology Department, Assistance Publique-Hôpitaux De Paris. Centre-Université De Paris, Paris, France.\', \'INSERM U1287, Gustave Roussy Cancer Center, Villejuif, France.\', \'Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.\', \'Institut Cochin, CNRS UMR8104, INSERM U1016, Université De Paris, Paris, France.\', \'Institut Universitaire De France, Paris, France.\', \'AP-HP, Hôpital Européen Georges Pompidou, Paris, France.\', \'Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China.\', \'Karolinska Institute, Department of Women\'s and Children\'s Health, Karolinska University Hospital, Stockholm, Sweden.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}